Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chimenti

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
The British Journal of Dermatology|April 10, 2010
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE studyD Thaçi, J-P Ortonne, S Chimenti, et al.
Journal of Psychiatric Research|December 13, 2019
Male-specific association of the 2p25 region with suicide attempt in bipolar disorderSophia C Gaynor, Eric T Monson, Marie E Gaine, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 16, 2025
CF airway epithelia display exaggerated host defense responses and prolonged cilia loss during RSV infectionJennifer A Bartlett, Eric D Huntemann, Sateesh Krishnamurthy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasisM Augustin, C Blome, C Paul, et al.
Cardiovascular Drugs and Therapy|October 24, 2001
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overloadS Masson, S Chimenti, M Salio, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseasesC Blandizzi, P Gionchetti, A Armuzzi, et al.
The British Journal of Dermatology|October 15, 2013
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)C Paul, L Puig, K Kragballe, et al.
The British Journal of Dermatology|September 18, 2016
Biosimilars for psoriasis: clinical studies to determine similarityA Blauvelt, L Puig, S Chimenti, et al.
The British Journal of Dermatology|January 17, 2007
A classification of psoriasis vulgaris according to phenotypeC E M Griffiths, E Christophers, J N W N Barker, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
The British Journal of Dermatology|April 10, 2010
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE studyD Thaçi, J-P Ortonne, S Chimenti, et al.
Journal of Psychiatric Research|December 13, 2019
Male-specific association of the 2p25 region with suicide attempt in bipolar disorderSophia C Gaynor, Eric T Monson, Marie E Gaine, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 16, 2025
CF airway epithelia display exaggerated host defense responses and prolonged cilia loss during RSV infectionJennifer A Bartlett, Eric D Huntemann, Sateesh Krishnamurthy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasisM Augustin, C Blome, C Paul, et al.
Cardiovascular Drugs and Therapy|October 24, 2001
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overloadS Masson, S Chimenti, M Salio, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseasesC Blandizzi, P Gionchetti, A Armuzzi, et al.
The British Journal of Dermatology|October 15, 2013
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)C Paul, L Puig, K Kragballe, et al.
The British Journal of Dermatology|September 18, 2016
Biosimilars for psoriasis: clinical studies to determine similarityA Blauvelt, L Puig, S Chimenti, et al.
The British Journal of Dermatology|January 17, 2007
A classification of psoriasis vulgaris according to phenotypeC E M Griffiths, E Christophers, J N W N Barker, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
Pageof 27